{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:34:48Z","timestamp":1790310888572,"version":"4.1.0"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Center Research and Development Fund","award":["23-A-18"],"award-info":[{"award-number":["23-A-18"]}]},{"name":"Health and Labour Sciences Research Grants for Clinical Research for Evidence-Based Medicine from the Ministry of Health, Labour, and Welfare of Japan"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0161081","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T17:36:21Z","timestamp":1471023381000},"page":"e0161081","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["Imaging Characteristics of Driver Mutations in EGFR, KRAS, and ALK among Treatment-Na\u00efve Patients with Advanced Lung Adenocarcinoma"],"prefix":"10.1371","volume":"11","author":[{"given":"Jangchul","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Y.","family":"Urayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Yatabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoaki","family":"Hida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"5840","DOI":"10.1002\/cncr.27637","article-title":"Driver mutations determine survival in smokers and never-smokers with stage IIIB\/IV lung adenocarcinomas","volume":"118","author":"PK Paik","year":"2012","journal-title":"Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1470-2045(10)70087-5","article-title":"New driver mutations in non-small-cell lung cancer","volume":"12","author":"W Pao","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1200\/JCO.2005.00.992","article-title":"Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrence","volume":"23","author":"T Mitsudomi","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa0810699","article-title":"Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma","volume":"361","author":"TS Mok","year":"2009","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1056\/NEJMoa0909530","article-title":"Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR","volume":"362","author":"M Maemondo","year":"2010","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1470-2045(11)70184-X","article-title":"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study","volume":"12","author":"C Zhou","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1470-2045(14)71173-8","article-title":"Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials","volume":"16","author":"JC Yang","year":"2015","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(12)70344-3","article-title":"Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study","volume":"13","author":"DR Camidge","year":"2012","journal-title":"Lancet Oncol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","article-title":"First-line crizotinib versus chemotherapy in ALK-positive lung cancer","volume":"371","author":"BJ Solomon","year":"2014","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","article-title":"Crizotinib versus chemotherapy in advanced ALK-positive lung cancer","volume":"368","author":"AT Shaw","year":"2013","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrclinonc.2013.22","article-title":"Surgery for NSCLC in the era of personalized medicine","volume":"10","author":"T Mitsudomi","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.lungcan.2012.03.013","article-title":"Clinicoradiologic characteristics of patients with lung adenocarcinoma harboring EML4-ALK fusion oncogene","volume":"77","author":"T Fukui","year":"2012","journal-title":"Lung Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cam4.172","article-title":"Anaplastic lymphoma kinase gene rearrangements in patients with advanced-stage non-small-cell lung cancer: CT characteristics and response to chemotherapy","volume":"3","author":"J Park","year":"2014","journal-title":"Cancer Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2353\/jmoldx.2006.050104","article-title":"A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancer","volume":"8","author":"Y Yatabe","year":"2006","journal-title":"J Mol Diagn"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner Society: glossary of terms for thoracic imaging","volume":"246","author":"DM Hansell","year":"2008","journal-title":"Radiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.1200\/JCO.2009.22.6993","article-title":"Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK","volume":"27","author":"AT Shaw","year":"2009","journal-title":"J Clin Oncol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/1078-0432.CCR-09-0802","article-title":"Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population","volume":"15","author":"SJ Rodig","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.lungcan.2012.11.021","article-title":"Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET\/CT","volume":"79","author":"H Choi","year":"2013","journal-title":"Lung Cancer"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.lungcan.2014.09.007","article-title":"Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?","volume":"86","author":"DF Halpenny","year":"2014","journal-title":"Lung Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1002\/cncr.27409","article-title":"Oncogene status predicts patterns of metastatic spread in treatment-naive nonsmall cell lung cancer","volume":"118","author":"RC Doebele","year":"2012","journal-title":"Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1097\/JTO.0b013e318274694e","article-title":"A dramatic response to crizotinib in a non-small-cell lung cancer patient with IHC-positive and FISH-negative ALK","volume":"7","author":"JM Sun","year":"2012","journal-title":"J Thorac Oncol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/JTO.0000000000000013","article-title":"Atypical negative ALK break-apart FISH harboring a crizotinib-responsive ALK rearrangement in non-small-cell lung cancer","volume":"9","author":"S Ren","year":"2014","journal-title":"J Thorac Oncol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S1556-0864(15)31604-X","article-title":"Epidermal growth factor receptor gene mutation and computed tomographic findings in peripheral pulmonary adenocarcinoma","volume":"1","author":"M Yano","year":"2006","journal-title":"J Thorac Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/01.pas.0000213285.65907.31","article-title":"Epidermal growth factor receptor mutation in lung cancer are linked to bronchioloalveolar differentiation","volume":"30","author":"H Blons","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"ref25","article-title":"Predicting EGFR mutation status in lung cancer: Proposal for a scoring model using imaging and demographic characteristics","author":"A Sabri","year":"2016","journal-title":"Eur Radiol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/RTI.0000000000000116","article-title":"Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma","volume":"29","author":"JS Hsu","year":"2014","journal-title":"J Thorac Imaging"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/JTO.0b013e3181fb7cf1","article-title":"Miliary never-smoking adenocarcinoma of the lung: strong association with epidermal growth factor receptor exon 19 deletion","volume":"6","author":"E Laack","year":"2011","journal-title":"J Thorac Oncol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/JTO.0000000000000069","article-title":"EGFR mutation and brain metastasis in pulmonary adenocarcinomas","volume":"9","author":"DY Shin","year":"2014","journal-title":"J Thorac Oncol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.resinv.2013.02.004","article-title":"Distinct features of distant metastasis and lymph node stage in lung adenocarcinoma patients with epidermal growth factor receptor gene mutations","volume":"51","author":"Y Enomoto","year":"2013","journal-title":"Respir Investig"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.tranon.2014.07.007","article-title":"NCI workshop report: clinical and computational requirements for correlating imaging phenotypes with genomics signatures","volume":"7","author":"R Colen","year":"2014","journal-title":"Transl Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","article-title":"Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach","volume":"5","author":"HJ Aerts","year":"2014","journal-title":"Nat Commun"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0161081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T13:56:28Z","timestamp":1568296588000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0161081"}},"subtitle":[],"editor":[{"given":"Giancarlo","family":"Troncone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":31,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0161081","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]}}}